Literature DB >> 14710901

Interaction between the hypothalamic-pituitary-adrenal axis and behavioural compensation following unilateral vestibular deafferentation.

Catherine M Gliddon1, Paul F Smith, Cynthia L Darlington.   

Abstract

Vestibular compensation is defined as the process of behavioural recovery that occurs following the loss of sensory input from one or both vestibular labyrinths. The visual and postural instability resulting from the vestibular damage must alter the homeostasis of the subject; however, very little research has been conducted that investigates the interaction between vestibular compensation and the adaptive stress response of the body, i.e. the hypothalamic-pituitary-adrenal (HPA) axis. The aim of this review is to describe and evaluate the experimental evidence indicating a link between vestibular compensation and the body's response to stress, via the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710901     DOI: 10.1080/00016480310000520

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Advances in Auditory and Vestibular Medicine.

Authors:  Mohamed A Hamid; Dennis R Trune; Mayank B Dutia
Journal:  Audiol Med       Date:  2009-12-01

2.  Cytosolic glucocorticoid receptor expression in the rat vestibular nucleus and hippocampus following unilateral vestibular deafferentation.

Authors:  Libby Lindsay; Ping Liu; Catherine Gliddon; Yiwen Zheng; Paul F Smith; Cynthia L Darlington
Journal:  Exp Brain Res       Date:  2004-12-03       Impact factor: 1.972

Review 3.  Interaction between Vestibular Compensation Mechanisms and Vestibular Rehabilitation Therapy: 10 Recommendations for Optimal Functional Recovery.

Authors:  Michel Lacour; Laurence Bernard-Demanze
Journal:  Front Neurol       Date:  2015-01-06       Impact factor: 4.003

Review 4.  The development of vestibular system and related functions in mammals: impact of gravity.

Authors:  Marc Jamon
Journal:  Front Integr Neurosci       Date:  2014-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.